Wave Life Sciences WVE
NASDAQ WVE
$3.40 -0.01 (-0.29%)
As of: Nov 11, 2026 · 3:42 PM EST

Wave Life Sciences (WVE) Cash & Equivalents (2014 - 2026)

Updated

Wave Life Sciences' Cash & Equivalents came in at $197.32 million for Q3 2026, up 0.6% from $196.22 million a year earlier but down 46.4% from the prior quarter.

Analysis

Wave Life Sciences (WVE) Cash & Equivalents (2014 - 2026) Analysis & Trends

At the end of FY2025, Wave Life Sciences' Cash & Equivalents was $602.07 million, up 99.3% from FY2024.

  • Cash & Equivalents has increased in each of the last three years, with a five-year compound annual growth rate of 26.7% (FY2020 to FY2025).
  • Going back by year, Cash & Equivalents was $302.08 million in FY2024 (+50.8%), $200.35 million in FY2023 (+126.4%), $88.5 million in FY2022 (-41.2%) and $150.56 million in FY2021 (-18.4%).
  • The five-year range for quarterly Cash & Equivalents is $61.71 million (Q1 2022) to $602.07 million (Q4 2025).
  • Year-over-year, Cash & Equivalents has increased for four consecutive quarters, with growth averaging 48.0% over the last eight quarters.
  • The fastest year-over-year change in Cash & Equivalents over five years came in Q1 2023 (growth of 236.4%), and the weakest in Q1 2022 (a decline of 58.5%).
  • Business Quant data shows WVE's Cash & Equivalents at $368.01 million (Q2 2026), $544.6 million (Q1 2026) and $602.07 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 16.91 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.55 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 400.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 7.94 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.82 Bn
10 Wave Life Sciences 672.50 Mn -1.27 Bn - 197.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 197.32 Mn
Jun 30, 2026 368.01 Mn
Mar 31, 2026 544.60 Mn
Dec 31, 2025 602.07 Mn
Sep 30, 2025 196.22 Mn
Jun 30, 2025 208.50 Mn
Mar 31, 2025 243.10 Mn
Dec 31, 2024 302.08 Mn
Sep 30, 2024 310.95 Mn
Jun 30, 2024 154.00 Mn
Mar 31, 2024 180.92 Mn
Dec 31, 2023 200.35 Mn
Sep 30, 2023 139.94 Mn
Jun 30, 2023 173.00 Mn
Mar 31, 2023 207.60 Mn
Dec 31, 2022 88.50 Mn
Sep 30, 2022 96.95 Mn
Jun 30, 2022 123.16 Mn
Mar 31, 2022 61.71 Mn
Dec 31, 2021 150.56 Mn
API Access

Wave Life Sciences Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=WVE&period=max&api_key=YOUR_API_KEY